Literature DB >> 3878881

Prevalence of anticentromere antibody in blood relatives of anticentromere positive patients.

A Ruffatti, L Artifoni, S Glorioso, A Calligaro, A Doria, P Gambari, S Todesco.   

Abstract

Anticentromere antibody (ACA) was investigated in 116 blood relatives of 22 ACA positive patients affected with scleroderma and, for comparison, in 82 healthy subjects matched for age and sex who belonged to 25 families. No relative showed any evident scleroderma symptom although in 8 an unusual cold sensitivity of the extremities was present. ACA at a low titer (40), was found in 4 relatives (3.44%), while it was absent in control sera. The 4 ACA positive relatives were first as well as second degree relatives of probands. Two had familial disease: one idiopathic chronic hypoparathyroidism and the other mental retardation. The third had myasthenia gravis and the fourth unusual cold sensitivity and allergic dermatitis. At present we cannot explain the significance of ACA occurrence in relatives of ACA positive patients. Followup clinical and serological studies could show a possible association of low titer of ACA with subclinical scleroderma features in patients who later develop overt disease.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3878881

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  4 in total

Review 1.  Antitopoisomerase and anticentromere antibodies in the sclerodermatosus complex.

Authors:  C G Kallenberg
Journal:  Clin Rev Allergy       Date:  1994

2.  Autoantibodies in patients with juvenile chronic arthritis and their immediate family relatives.

Authors:  T R Southwood; P J Roberts-Thomson; M J Ahern; K Shepherd; R McEvoy; J B Ziegler; J Edmonds
Journal:  Ann Rheum Dis       Date:  1990-12       Impact factor: 19.103

3.  Anticentromere antibodies in subjects with no apparent connective tissue disease.

Authors:  S L Lee; G J Tsay; R T Tsai
Journal:  Ann Rheum Dis       Date:  1993-08       Impact factor: 19.103

4.  Clinical correlation of anticentromere antibodies.

Authors:  M Zuber; R Gotzen; I Filler
Journal:  Clin Rheumatol       Date:  1994-09       Impact factor: 2.980

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.